Methodological Considerations in Clinical Trials for New MDR-TB Treatment Regimens

International Journal of Tuberculosis and Lung Disease - France
doi 10.5588/ijtld.16.0061
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Union Against Tuberculosis and Lung Disease

Related search

The Changing Treatment Landscape for MDR/XDR-TB — Can Current Clinical Trials Revolutionise and Inform a Brave New World?

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Improper Anti-Tb Treatment- Almost Certain Recipe for MDR-Tb

Journal of Evolution of Medical and Dental Sciences
2018English

Effectiveness and Safety of Meropenem/Clavulanate-Containing Regimens in the Treatment of MDR- And XDR-TB

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2016English

Challenging MDR-TB Clinical Problems- The Case for a New Global TB Consilium Supporting the Compassionate Use of New Anti-Tb Drugs

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

New Considerations in the Design of Clinical Trials for the Treatment of Acute Leukemia

Clinical Investigation
2011English

Relationship Between TB Treatment Phase and Knowledge of MDR TB With TB Patient’s Compliance

Jurnal Berkala Epidemiologi
2017English

Efficacy, Safety and Tolerability of Linezolid Containing Regimens in Treating MDR-TB and XDR-TB: Systematic Review and Meta-Analysis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2012English

Moxifloxacin Prophylaxis Against MDR TB, New York, New York, USA

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2015English

Meta-Analysis of Artificial Pancreas Trials: Methodological Considerations

The Lancet Diabetes and Endocrinology
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy